Abstract
Because little is known about intracranial astrocytomas occurring in those in the increasing geriatric population, twenty-three persons evaluated at the university affiliated hospitals over a 26-year period are reported. Progressive mental dysfunctions and motor deficits were the most common manifestations of disease. Glioblastoma multiforme was the predominant (87%) histopathologic diagnosis. The overall median period of survival in 21 evaluable individuals was four (range 0 to 15) months. Median survival was longer in patients who were more functional, who had tumors located in the temporal lobes of the brain, and who received more than one treatment modality. The absence of intercurrent disease or being in a younger ‘elderly’ age group was not associated with an improvement in prognosis. The poor survival of this group as well as the survivals quoted in the literature for those with glioblastoma multiforme demands a new therapeutic approach.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dujovny M, Charbel F, Berman SK, Diaz FG, Malik G, Ausman JI:Geriatric neurosurgery. Surg Neurol 28: 10–16, 1987
Cooney LM, Solitaire GB: Primary intracranial tumors in the elderly. Geriatrics 27: 94–104, 1972
Godfrey JB, Caird FI: Intracranial tumours in the elderly: diagnosis and treatment. Age and Ageing 13: 152–158, 1984
Moersch FP, Craig WM, Kernohan JW: Tumors of the brain in aged persons. Arch Neurol Psychiat 45: 235–245, 1941
Pennybacker J: Intracranial tumours in the aged. Edinburgh Med J 56: 590–600, 1949
Twomey C: Brain tumours in the elderly. Age and Ageing 7: 138–145, 1978
Zulch KJ: Histologic typing of tumours of the central nervous system. World Health Organization, Geneva. 1979, pp 43–45, 50
Beahrs OH, Henson D, Hutter R, Myers M: Manual for staging of cancer. Third edition. JB Lippincott, Phila. 1988
Scanlon PW, Taylor WF: Radiotherapy of intracranial astrocytomas: analysis of 417 cases treated from 1960 through 1969. Neurosurg 5: 301–308, 1979
Stage WS, Stein JJ: Treatment of malignant astrocytomas. Am J Roentgenol 120: 7–18, 1974
North B, Reilley P, Blumbergs P, Roder D, Esterman A: Malignant astrocytoma in South Australia: treatment and case survival. Med J Austral 153: 250–254, 1990
Nelson DF, Nelson JS, Davis DR, Chang CH, Griffin TW, Pajak TF: Survival and prognosis of patients with astrocytoma with atypical and anaplastic features. J Neuro-Oncol 3: 99–103, 1985
Walker M, Green S, Byar D, Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Owens G, Ransohoff J II, Robertson JT, Shapiro WR, Smith KR Jr, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. New Engl J Med 303: 1323–1329, 1980
Takeuchi K, Hoshino K: Statistical analysis of factors affecting survival after glioblastoma multiforme. Acta Neurochirurg 37: 57–73, 1977
Kun LE: The brain and spinal cord. In: Moss WT, Cox JD (eds) Radiation Oncology, Rationale, Technique, Results. CV Mosby, St. Louis 597–639, 1989
Leibel SA, Gutin PH, Wara WM, Silver PS, Larson DA, Edwards MSB, Lamb SA, Ham B, Barnett C, Philipps TL: Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for treatment of patients with recurrent malignant gliomas. Internat J Radiat Oncol Biol Phys 17: 1129–1139, 1989
Marchovsky JA, Welsh DM, Moran CJ: Hyperthermia treatment of brain tumors. Missouri Med 87: 29–33, 1990
Stylopoulos LA, George AE, De Leon MJ, Miller JD, Foo SH, Hiesiger E, Wise A: Longitudinal CT study of parenchymal brain changes in glioma survivors. Am J Neuroradiol 9: 517–522, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ampil, F., Fowler, M. & Kim, K. Intracranial astrocytoma in elderly patients. J Neuro-Oncol 12, 125–130 (1992). https://doi.org/10.1007/BF00172661
Issue Date:
DOI: https://doi.org/10.1007/BF00172661